551 related articles for article (PubMed ID: 26863149)
1. Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
Zhanel GG; Cheung D; Adam H; Zelenitsky S; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty A; Gin AS; Hoban DJ; Karlowsky JA
Drugs; 2016 Apr; 76(5):567-88. PubMed ID: 26863149
[TBL] [Abstract][Full Text] [Related]
2. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Zhanel GG; Esquivel J; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Hink R; Berry L; Schweizer F; Zhanel MA; Bay D; Lagacé-Wiens PRS; Walkty AJ; Lynch JP; Karlowsky JA
Drugs; 2020 Feb; 80(3):285-313. PubMed ID: 31970713
[TBL] [Abstract][Full Text] [Related]
3. The glycylcyclines: a comparative review with the tetracyclines.
Zhanel GG; Homenuik K; Nichol K; Noreddin A; Vercaigne L; Embil J; Gin A; Karlowsky JA; Hoban DJ
Drugs; 2004; 64(1):63-88. PubMed ID: 14723559
[TBL] [Abstract][Full Text] [Related]
4.
Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416552
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms.
Monogue ML; Thabit AK; Hamada Y; Nicolau DP
Antimicrob Agents Chemother; 2016 Aug; 60(8):5001-5. PubMed ID: 27353265
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial.
Solomkin J; Evans D; Slepavicius A; Lee P; Marsh A; Tsai L; Sutcliffe JA; Horn P
JAMA Surg; 2017 Mar; 152(3):224-232. PubMed ID: 27851857
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Eravacycline: A Novel Fluorocycline.
Alosaimy S; Abdul-Mutakabbir JC; Kebriaei R; Jorgensen SCJ; Rybak MJ
Pharmacotherapy; 2020 Mar; 40(3):221-238. PubMed ID: 31944332
[TBL] [Abstract][Full Text] [Related]
8. Eravacycline, a newly approved fluorocycline.
Lee YR; Burton CE
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1787-1794. PubMed ID: 31175478
[TBL] [Abstract][Full Text] [Related]
9. Eravacycline for the treatment of patients with bacterial infections.
Thakare R; Dasgupta A; Chopra S
Drugs Today (Barc); 2018 Apr; 54(4):245-254. PubMed ID: 29869646
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits.
Petraitis V; Petraitiene R; Maung BBW; Khan F; Alisauskaite I; Olesky M; Newman J; Mutlib A; Niu X; Satlin M; Singh RS; Derendorf H; Walsh TJ
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941646
[TBL] [Abstract][Full Text] [Related]
11. Tigecycline: a glycylcycline antimicrobial agent.
Doan TL; Fung HB; Mehta D; Riska PF
Clin Ther; 2006 Aug; 28(8):1079-1106. PubMed ID: 16982286
[TBL] [Abstract][Full Text] [Related]
12. Eravacycline (TP-434) is efficacious in animal models of infection.
Grossman TH; Murphy TM; Slee AM; Lofland D; Sutcliffe JA
Antimicrob Agents Chemother; 2015 May; 59(5):2567-71. PubMed ID: 25691636
[TBL] [Abstract][Full Text] [Related]
13. Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
Zhanel GG; Deng C; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Berry L; Schweizer F; Zhanel MA; Irfan N; Bay D; Lagacé-Wiens P; Walkty A; Mandell L; Lynch JP; Karlowsky JA
Drugs; 2021 Feb; 81(2):233-256. PubMed ID: 33247830
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.
Sutcliffe JA; O'Brien W; Fyfe C; Grossman TH
Antimicrob Agents Chemother; 2013 Nov; 57(11):5548-58. PubMed ID: 23979750
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent.
Meagher AK; Ambrose PG; Grasela TH; Ellis-Grosse EJ
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):165-71. PubMed ID: 16105560
[TBL] [Abstract][Full Text] [Related]
16. Eravacycline: A Review in Complicated Intra-Abdominal Infections.
Scott LJ
Drugs; 2019 Feb; 79(3):315-324. PubMed ID: 30783960
[TBL] [Abstract][Full Text] [Related]
17. Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline.
Newman JV; Zhou J; Izmailyan S; Tsai L
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150464
[TBL] [Abstract][Full Text] [Related]
18. Mass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy Subjects.
Newman JV; Zhou J; Izmailyan S; Tsai L
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559132
[TBL] [Abstract][Full Text] [Related]
19.
Morrissey I; Olesky M; Hawser S; Lob SH; Karlowsky JA; Corey GR; Bassetti M; Fyfe C
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843999
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of Bacteroides and Parabacteroides species.
Goldstein EJC; Citron DM; Tyrrell KL
Anaerobe; 2018 Aug; 52():122-124. PubMed ID: 30018028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
